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Abstract
Similar multicellular structures can evolve within the same organism that may have different evolutionary histories, be
controlled by different regulatory pathways, and play similar but nonidentical roles. In the human fungal pathogen Candida
albicans, a quite extraordinary example of this has occurred. Depending upon the configuration of the mating type locus (a/
a versus a/a or a/a), C. albicans forms alternative biofilms that appear similar morphologically, but exhibit dramatically
different characteristics and are regulated by distinctly different signal transduction pathways. Biofilms formed by a/a cells
are impermeable to molecules in the size range of 300 Da to 140 kDa, are poorly penetrated by human polymorphonuclear
leukocytes (PMNs), and are resistant to antifungals. In contrast, a/a or a/a biofilms are permeable to molecules in this size
range, are readily penetrated by PMNs, and are susceptible to antifungals. By mutational analyses, a/a biofilms are
demonstrated to be regulated by the Ras1/cAMP pathway that includes Ras1RCdc35RcAMP(Pde2—|)
RTpk2(Tpk1)REfg1RTec1RBcr1, and a/a biofilms by the MAP kinase pathway that includes MfaRSte2R (Ste4, Ste18,
Cag1)RSte11RHst7RCek2(Cek1)RTec1. These observations suggest the hypothesis that while the upstream portion of
the newly evolved pathway regulating a/a and a/a cell biofilms was derived intact from the upstream portion of the
conserved pheromone-regulated pathway for mating, the downstream portion was derived through modification of the
downstream portion of the conserved pathway for a/a biofilm formation. C. albicans therefore forms two alternative
biofilms depending upon mating configuration.
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Introduction
During convergent evolution, similar adaptive forces can lead to
similar multicellular structures through different evolutionary
histories [1]. Similar multicellular structures, however, may also
evolve within the same organism that appear morphologically
similar, but may have different evolutionary histories and similar
but not necessarily identical functions [2,3]. Here we describe an
extraordinary example of the latter, which not only reveals how an
organism may use similar structures for different purposes, but also
provides clues to how new signal transduction pathways evolve.
We have found that depending upon the configuration of the
mating type locus (a/a versus a/a or a/a), the opportunistic
fungal pathogen Candida albicans forms alternative biofilms that are
morphologically similar, but which are regulated by distinctly
different signal transduction pathways and exhibit quite different
characteristics consistent with different roles in the life history of
this human pathogen.
The majority of C. albicans strains are heterozygous (a/a) at the
mating type locus [4–7]. These strains cannot undergo white to
opaque switching, a necessary phenotypic transition in the
acquisition of mating competency, because switching as well as
mating are repressed by the a1-a2 corepressor complex [4,8,9].
We can assume that because most strains of C. albicans in nature
are a/a, the majority of biofilms that form in mammalian hosts, as
well as on catheters and prosthetics, are a/a. These a/a biofilms
appear to play the traditional role of providing a controlled
environment that protects populations from outside challenges,
such as host antibodies, host white blood cells, and antifungal
drugs [10–14]. When C. albicans undergoes homozygosis from a/a
to either a/a or a/a, it is able to switch from white to opaque, the
latter the mating competent phenotype [8,9]. Like a/a cells,
unisexual population of white a/a or a/a cells form robust
biofilms on the proper substratum [15,16]. The thickness of these
biofilms can be enhanced 30% to 50% by adding minority opaque
cells of opposite mating types, which are a source of pheromone
[15]. In the absence of opaque cells of the opposite mating type,
unisexual populations of a/a cells self-induce biofilm formation by
releasing a-pheromone and unisexual populations of a/a cells self-
induce by releasing a-pheromone, in a mating type-nonspecific,
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made up of white MTL-homozygous cells facilitate mating
between embedded minority opaque a/a and a/a cells, which
can be as far apart as 30 mm, suggesting that at least one role of
MTL-homozygous white cell biofilms may be to protect phero-
mone gradients that direct chemotropism in the fusion process
[15,19].
By mutational analysis, we recently identified the major
components of the pathway that regulate pheromone-induced
biofilm formation by white cells, from the pheromone signal
through the transduction pathway and the targeted transcription
factor Tec1 [15–24]. We found that a-pheromone first induces
white a/a cells to adhere to a plastic or silicone elastomer surface
to form a basal yeast cell layer, the first step in biofilm formation
[25], and then induces biofilm maturation, which includes the
formation of hyphae oriented vertically to the substratum and the
deposition of an extracellular polymolecular matrix [15–24]. The
upper portion of the white cell pheromone response pathway
includes the same pheromone signals, pheromone receptors,
trimeric G-protein complex, MAP kinase cascade, and MAP
kinase scaffold as the upper portion of the opaque cell pheromone
response pathway in the mating process [17,18,20–23]. This
common upper portion of the pathway in white cells, however,
then targets the transcription factor Tec1 [22], rather than Cph1,
the transcription factor targeted by the opaque pheromone
response pathway for the mating response [26,27]. Tec1 was
demonstrated to bind to the cis-acting white-specific pheromone
response element WPRE in the promoters of biofilm-related genes,
resulting in the formation of a white cell biofilm [18,22]. Given
that a/a cells repress pheromone synthesis, we assumed that a/a
biofilms, which are morphologically similar to MTL-homozygous
biofilms, were regulated by a pathway other than the MAP kinase
pathway, which regulates MTL-homozygous biofilm formation.
Rather than the mating pheromone, it has been proposed that the
signal for a/a biofilm formation may simply be mechanical,
through contact with the proper tissue or prosthetic surface [28].
The pathway regulating a/a biofilm formation, however, had not
been elucidated, as had the pathway for MTL-homozygous biofilm
formation. Genes implicated by mutational analysis in the
regulation of a/a biofilm formation included EFG1 [29,30],
BCR1 [28,31], and TEC1 [28,31].
Here, we have explored two hypotheses related to the
differences between MTL-heterozygous (a/a) and MTL-homozy-
gous (a/a, a/a) biofilms, first that they play different roles in the
life history of C. albicans and second that formation of each is
regulated by a different signal transduction pathway. In regard to
the first hypothesis, we demonstrate that a/a biofilms are highly
impermeable to molecules in the 300 Da to 140 kDa range, are
poorly penetrated by human polymorphonuclear leukocytes
(PMNs), and are resistant to fluconazole treatment. Biofilms
formed by a/a or a/a cells, on the other hand, are highly
permeable to molecules in the 300 Da to 140 kDa range, are
readily penetrated by human PMNs, and are highly susceptible to
fluconazole. In regard to the second hypothesis, we demonstrate
that the formation of biofilms by a/a cells is regulated by the
Ras1/cAMP pathway, not the MAP kinase pathway, whereas the
formation of biofilms by white a/a cells is regulated by the MAP
kinase pathway [15–23], not the Ras1/cAMP pathway. Further-
more we show that during a/a biofilm formation, the Ras1/
cAMP pathway activates the transcription factor cascade Efg1R
Tec1RBcr1. We have, therefore, demonstrated that although a/a
and a/a biofilms are morphologically similar, they exhibit
different phenotypic properties and are regulated by different
signal transduction pathways. Our results further suggest that
MTL-heterozygous biofilms provide the traditional protective,
impermeable environment for commensalism and infection,
whereas unisexual MTL-homozygous biofilms provide a more
permeable environment that may facilitate mating [15,19].
Results
a/a and MTL-homozygous (a/a and a/a) Biofilms Differ in
Permeability, Human Leukocyte Penetrance, and
Susceptibility to Fluconazole
To test for differences in permeability, we developed biofilms of
a/a, a/a and a/a cells of two natural, genetically unrelated
strains, P37039 and P37037, and the common laboratory strain
SC5314. Biofilms were developed for 48 h on a silicone elastomer
surface, then overlaid with a solution of the dye SYPRO Ruby,
which has a molecular weight of 1.6 kDa [32,33], and incubated
for an additional 30 min. Biofilms were then examined without
fixation by laser scanning confocal microscopy (LSCM). All nine
strains examined had been transformed with a construct
containing GFP driven by the constitutive actin promoter (Table
S1) in order to assess formation of an intact biofilm and biofilm
thickness. Side views of GFP-labeled, LSCM projections revealed
that a/a, a/a, and a/a cells of strain P37039 (Figure 1A, C, and
E, respectively), a/a, a/a and a/a cells of strain P37037
(unpublished data), and a/a and a/a cells of strain SC5314
(Figure 1G and I, respectively) all formed dense, relatively
contiguous biofilms. The mean (6 standard deviation) thickness
of a/a biofilms of the three respective strains were 7565 mm
Author Summary
Single-celled microbes can form biofilms, or aggregates of
cells that adhere to one another on a surface, in response
to many environmental factors. Like many microbial
pathogens, the yeast Candida albicans can form biofilms
that normally provide protective environments against
antifungals, antibodies, and white blood cells, thus
ensuring higher rates of survival in response to assault
by drugs or the human immune system. We report that
while a majority (around 90%) of C. albicans strains form
traditional biofilms that are impermeable to molecules of
low and high molecular weight, and that are impenetrable
to white blood cells, a minority (around 10%) form biofilms
that are both permeable and penetrable. Formation of the
minority-type alternative biofilms is dictated by a change
at a single genetic locus, the mating type locus.
Homozygous a/a or a/a cells are mating-competent,
whereas the heterozygous a/a cells are mating-incompe-
tent. Cells of the mating-incompetent a/a genotype form
the impermeable, traditional biofilm, whereas the mating-
competent a/a or a/a genotype forms the permeable
biofilm. The characteristics of a/a and a/a biofilms are
consistent with a suggested role in mating by facilitating
the transfer of hormone signals through the permeable
biofilm. The two types of biofilm are also regulated by
different signal transduction pathways: the a/a form by
the Ras1/cAMP pathway, and the a/a or a/a forms by the
MAP kinase pathway. Components of the latter pathway
suggest that its downstream portion evolved from the a/a
pathway. C. albicans, therefore, forms two superficially
similar biofilms, exhibiting very different permeability
characteristics, regulated by different signal transduction
pathways, dictated by different mating type locus
configurations, and serving quite different purposes in its
life history.
Two biofilms in Candida albicans
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biofilms 5664 mm( N=9), 5763 mm( N=9) and 5163 mm
(N=9), and that of white a/a biofilms 6164 mm( N=9),
5663 mm( N=9), and 5463( N=9) (Figure 1U). MTL-heterozy-
gous biofilms were therefore on average approximately 28%
thicker than MTL-homozygous biofilms. Both MTL-heterozygous
and MTL-homozygous biofilms of all three strains were composed
of a thin basal layer (10% to 20% of thickness) of yeast cells at the
substratum and a thick upper region (80% to 90% of thickness)
composed primarily of vertically oriented hyphae and extracellular
matrix (unpublished data). SYPRO Ruby penetrated into only the
upper 1563% (N=9) of a/a biofilms (Figure 1B,H,U), but
penetrated through 100% (N=9) of a/a biofilms and 100%
(N=9) of a/a biofilms (Figure 1D,F,J,U). Similar results were
obtained for all three strains with the dye ConA (unpublished
data), which has a molecular weight of 104 to 112 kDa,
approximately 70 times that of SYPRO Ruby.
If a/a and a/a biofilms are more permeable than a/a biofilms,
they should also be more susceptible to antifungals. To test this
prediction, biofilms of the a/a, a/a, and a/a derivatives of the
three strains, all expressing GFP regulated by the constitutive actin
promoter (see Table S1), were developed for 48 h, then treated
with 24 mg per ml of fluconazole, which has a molecular weight of
306 daltons, for 24 and 48 h. The fluconazole solution was
dispersed on the top of each biofilm. Since most vital stains of
metabolically active cells (i.e., living cells) could have permeability
Figure 1. a/a biofilms differ from a/a and a/a biofilms in permeability, antifungal susceptibility, and human leukocyte penetration.
Laser scanning confocal microscopy of biofilms was used to image the permeability of SYPRO Ruby and penetration by DiI-labeled human PMNs. The
strains had been transformed so that each expressed green fluorescent protein (GFP) under the regulation of the actin promoter. See Table S1 for
genotypes. (A, C, E, G, I) GFP fluorescence for assessing biofilm thickness and continuity. (B, D, F, H, J) SYPRO Ruby penetration 30 min after
application to top of biofilms. (K through T) Penetrance by DiI-stained PMNs of two representative biofilms of each strain 3 h after the PMNs were
dispersed on the top of biofilms. All images are representative of 9 biofilms for each strain and condition. (U) Biofilm thickness, permeation by SYRPO
Ruby and penetration by PMNs. (V) Susceptibility to fluconazole, measured by percent cell death assessed with the dye Dead Red. In panels U and V,
values are given as means 6 standard derivatives. Scale bar for all biofilms (A through T) in panel A equals 50 mm.
doi:10.1371/journal.pbio.1001117.g001
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biofilms, then staining cells for cell death with the dye Dead Red
[34]. The proportion of dead cells was 3%, 5%, and 6% in the a/
a parental strains SC5314, P37037, and P37039, but varied
between 31% and 49% in the a/a and a/a derivatives of these
strains (Figure 1V). The average fold difference for a/a versus a/
a or a/a cells was, therefore, 9-fold. These results demonstrate
that a/a biofilms are far less susceptible to fluconazole than a/a
or a/a biofilms.
To test for differences in human white blood cell penetrance,
fresh human polymorphonuclear leukocytes (PMNs) were distrib-
uted along the surface of 48-h biofilms of the MTL-heterozygous
strains of P37039, P37037, and SC5314, as well as their MTL-
homozygous derivatives (Table S1), and incubated for 3 h. Prior to
distribution, PMNs were stained with the vital membrane dye DiI
[35,36]. Since the excitation wavelength for imaging DiI overlaps
that for GFP, transmitted light images rather than GFP images
were used to assess biofilm thickness. Thickness is indicated by
dotted white lines in Figure 1K–T. PMNs penetrated into only the
upper 1163% (N=9) of P37039 a/a biofilms (Figure 1K,L,U),
but into 100% of P37039 a/a biofilms (Figure 1M,N) and
into100% of P37039 a/a biofilms (Figure 1O,P,U). Similar
differences were observed between a/a versus a/a or a/a
biofilms of strain P37037 (Figure 1U) and Sc5314 (Figure 1Q
through T,U). These results demonstrate that in addition to
dramatic differences in permeability, a/a biofilms are far less
penetrable by human PMNs than unisexual MTL-homozygous
(a/a or a/a) biofilms.
a/a Biofilms Are Not Regulated by the MAP Kinase
Pathway
Self-induction of a basic biofilm in an a/a white cell
population, to which no opaque a/a cells are added, is mediated
through the release of a-pheromone by minority a/a opaque cells
produced by low frequency switching, in a paracrine-like fashion
[16]. Addition of a/a opaque cells, which provide a-pheromone to
a white a/a cell population, enhances biofilm formation by over
50% [16–18,20–24]. a-pheromone stimulates white cell biofilm
formation by binding to the a-pheromone receptor Ste2 on white
a/a cells, which activates the MAP kinase signal transduction
pathway. This pathway targets the transcription factor Tec1 [22].
The pheromone response pathway for a/a cells includes the
pheromone receptor Ste2, the trimeric G protein complex, the
MAP kinases Ste11, Hst7, and Cek1/Cek2, and the scaffold
protein Cst5 and Tec1. Activation of white a/a cells involves the
alternative a-pheromone and receptor Ste3 [16]. This relatively
new pathway, which evolved in the ancestor of C. albicans and C.
dubliniensis approximately 20 to 40 million years ago [37],
borrowed intact the signals, receptors, trimeric G-protein complex,
MAP kinase cascade, and scaffold protein from the pheromone
response pathway involved in mating of opaque cells [24]. It
seemed unlikely to us that the pathway for a/a biofilm formation,
presumably a conserved and more ancient pathway than that of
the white pheromone response pathway, would be regulated by
genes derived from the mating process, given that these genes are
suppressed in a/a cells by the a1-a2 corepressor [38,39]. To
exclude the MAP kinase pathway definitively, we assessed biofilm
formation in the following deletion mutants that were generated in
the a/a strain SC5314: ste2/ste2, the deletion mutant for the a-
pheromone receptor; ste11/ste11 and hst7/hst7, the deletion
mutants for the MAP kinases Ste11 and Hst7; cek1/cek1 cek2/
cek2, the double deletion mutant for the partially redundant MAP
kinases Cek1 and Cek2 [20]; and tec1/tec1, the deletion mutant for
the transcription factor Tec1 (Table S2) [22]. We also tested the
a/a mutant cph1/cph1, the deletion mutant of the transcription
factor Cph1targeted by the MAP kinase cascade in the opaque
pheromone response pathway (Table S2) [26,27]. Adhesion to a
plastic surface after 16 h (Figure 2A,B), subsequent biofilm mass
(Figure 2C), the level of ß-glucan released by the biofilm
(Figure 2D), biofilm thickness (Figure 2E), and cell density at the
substratum and 20 mm above the substratum in biofilms (Figure 2F)
were similar for the a/a control strain SC5314 and the mutant
derivatives ste2/ste2, ste11/ste11, hst7/hst7, cek1/cek1 cek2/cek2, and
cph1/cph1. Since overexpression of STE11 has been shown to
activate the MAP kinase cascade in a pheromone- and receptor-
independent fashion [22], we tested whether overexpression
induced by doxycycline in strain SC5314-TETp-STE11 affected
a/a biofilm formation. The characteristics of biofilms formed by
cells in which STE11 was overexpressed were similar to those of
control SC5314 cells (Figure 2A through F). In the tec1/tec1
mutant, however, adhesion was reduced by over 95%
(Figure 2A,B), biofilm biomass by 90% (Figure 2C), ß-glucan
release by 82% (Figure 2D), and biofilm thickness by 50%
(Figure 2E). Cell density at the substratum and 20 mm above it in a
biofilm was dramatically reduced (Figure 2F). These results
demonstrate that the pheromone response pathway, from receptor
through the MAP kinase pathway, is not involved in a/a biofilm
formation, but the targeted transcription factor, Tec1, does play a
role, as previously reported [28,31]. Our results indicate, however,
that Tec1 is regulated by a pathway other than the MAP kinase
pathway in a/a biofilm formation.
a/a Biofilms Are Regulated by the Ras1/cAMP Pathway
In a/a strains of C. albicans, the Ras1/cAMP pathway has been
shown to be involved in the response of cells to a number of
environmental cues. In particular, it has been demonstrated to
play a role in the induction of filamentation [40–43], a major
component of a mature biofilm [10,11], in CO2, GlcNAc, and
glucose induction of the white to opaque switch in MTL-
homozygous cells [44], and in stationary phase and the starvation
response [43]. We tested whether the Ras1/cAMP pathway also
regulated a/a biofilm formation. The Ras1/cAMP pathway
includes the following components: Ras1, a GTPase that activates
adenylate cyclase [40,42]; Cdc35, the only adenylate cyclase in C.
albicans [45], which catalyzes the formation of cAMP; Pde2, a
phosphodiesterase that acts as a negative regulator by hydrolyzing
cAMP [46]; and Tpk1 and Tpk2, isoforms of cAMP-dependent
protein kinase [47,48]. The deletion mutants tested for biofilm
formation were derivatives of the a/a strain SC5314 and included
ras1/ras1, cdc35/cdc35, pde2/pde2, tpk1/tpk1, and tpk2/tpk2 (Table
S2). Complemented a/a derivatives of ras1/ras1, pde2/pde2, tpk1/
tpk1, and tpk2/tpk2 were generated with the respective wild type
gene under the regulation of a tetracycline (doxycycline)-inducible
promoter (Table S2) [49]. The complemented strains were ras1/
ras1-TETp-RAS1, pde2/pde2-TETp-PDE2, tpk1/tpk1-TETp-TPK1,
and tpk2/tpk2-TETp-TPK2 (Table S2). A complemented derivative
of cdc35/cdc35 was generated by transformation with CDC35
under the regulation of the MET3 promoter, to generate cdc35/
cdc35-METp-CDC35 [42]. We also complemented ras1/ras1 with a
constitutively activated form of Ras1, Ras1V13 [40], to generate
ras1/ras1-TETp-RAS1V13 (Table S2).
Deletion of RAS1, CDC35, and TPK2 resulted in maximum
reductions in all of the measured biofilm parameters. Adhesion to
a plastic surface after 16 h (Figure 3B,C), subsequent biofilm
biomass (Figure 3D), biofilm thickness (Figure 3E), the release of ß-
glucan (Figure 3F), expression of BCR1, SUN41, and ALS3
(Figure 3G), genes previously demonstrated to be up-regulated
in a/a biofilms [28,31,50,51], and cell density at the substrate and
Two biofilms in Candida albicans
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mutants ras1/ras1, cdc35/cdc35, and tpk2/tpk2, when compared to
either the original parental strain SC5314 or to the relevant
complemented strains. Deletion of PDE2 resulted in biofilm
parameters either equal to or slightly higher than those of the
parental control strain, but overexpression in the complemented
strain by the addition of doxycycline resulted in dramatically
decreased or negligible biofilm parameters (Figure 3B through H),
since Pde2 is a negative regulator of cAMP. Deletion of TPK1
resulted in a partial reduction of biofilm parameters, whereas
deletion of TPK2 resulted in maximum reduction (Figure 3B
through H). These latter results can be interpreted in two ways.
First, Tpk1 and Tpk2 may perform different functions. Tpk2 may
have a direct role, while Tpk1 may act as an enhancer.
Alternatively, the two may be partially redundant, with Tpk2
able to compensate partially for the loss of Tpk1, but Tpk1 not
able to partially compensate for the loss of Tpk2. Overexpression
of RAS1V13, the activated form of RAS1 [40], by addition of
Figure 2. The MAP kinase response pathway plays no role in a/a biofilm formation. Deletion mutants generated in a/a cells of strain
SC5314 for the a-pheromone receptor (ste2/ste2) and the MAP kinases (ste11/ste11, hst7/hst7, cek1/cek1 cek2/cek2), components of the upstream
portion of the pheromone response pathway (see Table S2 for mutant origins and genotypes), formed normal a/a biofilms. The deletion mutant of
CPH1, which encodes the targeted transcription factor in the opaque cell pheromone response, also formed normal biofilms. Overexpression of STE11
in a wild type background by adding doxycycline to strain SC5314-TETp-STE11 did not enhance biofilm formation. However, deletion of TEC1, which
encodes the targeted transcription factor in the pheromone response pathway of white a/a cell biofilm formation, blocked a/a biofilm formation, as
previously described [31]. (A) Quantitation of adhesion to a plastic surface after 16 h. (B) Images of adhesion of select strains to the plastic surfaceo f
wells after 16 h. (C) Biomass of biofilms formed after 48 h on a silicone elastomer surface. (D) ß-glucan released into the medium by 48 h biofilms. (E)
Thickness of 48 h biofilms. (F) Cell density at the substratum (0 mm) and 20 mm above the substratum (20 mm) for 48 h biofilms of select strains. Data
in panels A, C, D, and E are presented as mean 6 standard deviation (error bar). Data are from eight measurements, two per biofilm preparation. Dox,
doxycycline. Scale bar in panel H equals 100 mm.
doi:10.1371/journal.pbio.1001117.g002
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PLoS Biology | www.plosbiology.org 5 August 2011 | Volume 9 | Issue 8 | e1001117Figure 3. The Ras1/cAMP pathway regulates a/a biofilm formation. (A) Key to the mutants used in the analysis of the Ras1/cAMP pathway in
panels B through H. SC5314 (a/a) was the parent strain (see Table S2 for origins and genotypes of mutants). (B) Quantitation of adhesion to a plastic
surface after 16 h. (C) Images of adhesion of select strains to the plastic surface of wells after 16 h. (D) Biomass of biofilms formed on a silicone
elastomer surface after 4 h. (E) Thickness of 48 h biofilms. (F) ß-glucan released into the media by 48 h biofilms. (G) The expression of three genes
(BCR1, SUN41, ALS3), which are involved in a/a biofilm formation, assessed by reverse transcription-polymerase chain reaction (RT-PCR). Actin 1
expression is constitutive and used to assess loading. (H) Representative images of cell density at the substrate and 20 mm above the substratum for
48 h biofilms of select strains. Data in panels B, D, E, and F are presented as mean 6 standard deviation (error bar). Data are from eight
Two biofilms in Candida albicans
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increase in select parameters, including adhesion (Figure 3B,C),
biofilm biomass (Figure 3D), biofilm thickness (Figure 3E), and ß-
glucan release (Figure 3F), to levels above that in control strain
SC5314, as did the deletion of PDE2. Together, these results
demonstrate that the Ras1/cAMP pathway regulates a/a biofilm
formation, from the acquisition of adhesion and formation of the
basal layer of yeast cells at the substrate, through maturation,
resulting in hypha formation and the deposition of the biofilm
matrix.
a/a Biofilms Are Not Regulated by the Ras1/cAMP
Pathway
The formation of white a/a biofilms has been demonstrated to
be regulated by the MAP kinase pathway [16–18,20–24]. To test
whether the formation of MTL-homozygous biofilms was also
regulated by the Ras1/cAMP pathway, a/a derivatives of the null
mutants of two key components of the pathway, ras1/ras1 and
tpk2/tpk2 (Table S2), were analyzed for several characteristics of
biofilm formation. First, the two mutants were tested for a-
pheromone-induced adhesion after 16 h of treatment on a plastic
surface [15]. Cells of both a/a mutants ras1/ras1 and tpk2/tpk2
exhibited a-pheromone-induced adhesion similar to that of the a/
a derivative of the parental strain SC5314 (Figure S1A). Biofilms
formed by white cell populations of the two mutants on silicon
elastomer in the absence of minority opaque a/a cells, a source of
a-pheromone (unenhanced state; [15]), exhibited biomass (Figure
S1B), released b-glucan level (Figure S1C), and cell density at the
substrate and 20 mm above the substrate (Figure S1D), similar to
that of the a/a derivative of the wild type strain SC5314. In the
presence of 10% opaque a/a cells, a source of a-pheromone [15],
biofilm biomass (Figure S1B), and released b-glucan (Figure S1C)
was enhanced by approximately the same levels in ras1/ras1 and
tpk2/tpk2 cells as in the a/a derivative of the wild type strain
SC5314. Analysis of the cell types within the upper three-fourths of
the a/a derivatives of ras1/ras1 and tpk2/tpk2 revealed vertically
oriented hyphae (Figure S1F and S1H, respectively), absent from
the a/a derivatives of ras1/ras1 and tpk2/tpk2 (Figure S1E and G,
respectively). Viewing the cell types in a/a derivatives of both the
mutant ras1/ras1 and tpk2/tpk2 revealed hypha formation in the
upper three-fourths of the biofilm formed (Figure S1I and J,
respectively). These results demonstrate that although the Ras1/
cAMP pathway is essential for biofilm formation in a/a cells,
including formation of vertically oriented hyphae and matrix in
the upper portion of the biofilm, it is not essential for a/a biofilm
formation. It should be noted that the hyphae formed in biofilms
by the a/a derivatives of ras1/ras1 and tpk2/tpk2 were indistin-
guishable from those formed in biofilms of wild type a/a and a/a
strains.
Efg1, Tec1, and Bcr1 Function, in That Order,
Downstream of the Ras1/cAMP Pathway
Having demonstrated that the Ras1/cAMP pathway regulates
a/a biofilm formation, we examined the dependent relationship of
this pathway with the three transcription factors that had
previously been implicated in a/a biofilm formation. Efg1, a
DNA binding protein [52] homologous to transcription factors
involved in morphogenesis in a number of other fungal species
[53–55], was shown by Ramage et al. [30] to be required for a/a
biofilm formation. Bcr1, a C2H2 zinc finger protein known to bind
to DNA as well as RNA and proteins [56], has also been shown to
be necessary for the expression of ALS3, which encodes an adhesin
that confers adherence in vitro and plays a role in a/a biofilm
formation [28,31]. Bcr1 has been demonstrated to function
downstream of Tec1, the third transcription factor critical for a/
a biofilm formation [28,31]. Efg1 and Tec1 have been shown to
function downstream of the Ras1/cAMP pathway in the
regulation of hypha formation in a/a cells [57,58], but Bcr1 has
not been shown to be involved in hypha formation. Before
assessing dependencies, we had to demonstrate that the aberrant
phenotypes of the a/a mutants efg1/efg1, bcr1/bcr1, and tec1/tec1
(Table S2) were similar to those of the a/a deletion mutant ras1/
ras1, cdc35/cdc35, and tpk2/tpk2, using the same assays employed to
characterize the latter. The a/a deletion mutants efg1/efg1 and
bcr1/bcr1 exhibited dramatic reductions in adhesion (Figure 4A,B),
biofilm biomass (Figure 4C), ß-glucan release (Figure 4D), biofilm
thickness (Figure 4E), and cell density at the substrate and 20 mm
above it (Figure 4F). These reductions were similar to those
observed for the a/a mutants ras1/ras1, cdc35/cdc35, and tpk2/tpk2
(Figure 3B,C,D,F,H). As already described, the a/a deletion
mutant tec1/tec1 also exhibited decreases similar to those of the a/
a deletion mutants ras1/ras1, cdc35/cdc35, and tpk2/tpk2 for
adhesion (Figure 2A,B), biofilm mass (Figure 2C), released ß-
glucan (Figure 2D), biofilm thickness (Figure 2E), and cell density
(Figure 2F). The a/a mutant tec1/tec1 also expressed reduced
levels of BCR1, SUN41, and ALS3 (see tec1/tec1-TETp-EFG1,
minus doxycycline, in Figure 5F), as did the mutants ras1/ras1,
cdc35/cdc35, and tpk2/tpk2 (Figure 3G). The a/a mutants efg1/efg1
and bcr1/bcr1 also exhibited decreases in the expression of these
three biofilm-related genes (see efg1/efg1-TETp-EFG1 and bcr1/
bcr1-TETp-EFG1, minus doxycycline, in Figure 5F).
Nobile and Mitchell [28] previously established that Bcr1
expression was regulated by Tec1. We therefore focused on the
functional relationship of Efg1, first to the upstream Ras1/cAMP
pathway, and then to Tec1 and Bcr1, using a promoter-regulated
overexpression strategy. The a/a mutants ras1/ras1, cdc35/cdc35,
and tpk2/tpk2 were transformed with EFG1 under the regulation of
the tetracycline (doxycycline)-inducible promoter, TETp, generat-
ing strains ras1/ras1-TETp-EFG1, cdc35/cdc35-TETp-EFG1, and
tpk2/tpk2-TETp-EFG1 (Table S2). If normal a/a biofilms were
formed when EFG1 was overexpressed in these mutant back-
grounds, then Efg1 functioned downstream of the Ras1/cAMP
pathway. Two parameters were assayed, adhesion and up-
regulation of biofilm genes. Overexpression of EFG1 induced by
the addition of the inducer doxycycline rescued the mutant
phenotypes of ras1/ras1, cdc35/cdc35, and tpk2/tpk2, resulting in
wild type levels of adhesion (Figure 5A) and wild type expression of
BCR1, SUN41, and ALS3 (Figure 5B). These results indicate that
Efg1 functions downstream of the Ras1/cAMP pathway.
To determine the functional order of Efg1and the factors Tec1
and Bcr1, the a/a overexpression mutants efg1/efg1-TETp-TEC1
and efg1/efg1-TETp-BCR1 were generated (Table S2) and tested. If
normal a/a biofilms were formed when TEC1 or BCR1 was
overexpressed in an efg1/efg1 background, then Tec1 and Bcr1
functioned downstream of Efg1. Overexpression of TEC1 or BCR1
by the addition of doxycycline rescued the efg1/efg1 mutant
phenotype for both adhesion and gene expression (Figure 5C and
measurements, two per biofilm preparation. (2Met, 2Cys), in the absence of methionine and cysteine, a condition that activates the methionine
promoter (Metp); (+Dox), in the presence of doxycycline, which activates the tetracycline-inducible promoter (TETp). Scale bar in panel H equals
100 mm.
doi:10.1371/journal.pbio.1001117.g003
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downstream of Efg1. If true, then overexpressing EFG1 in the
mutants tec1/tec1 or bcr1/bcr1 would not rescue either mutant
phenotype. The a/a overexpression mutants tec1/tec1-TETp-
EFG1 and bcr1/bcr1-TETp-EFG1 were, therefore, generated
(Table S2) and tested. Overexpression of EFG1 by the addition
of doxycycline did not rescue either the tec1/tec1 or bcr1/bcr1
mutant phenotype (Figure 5E,F), supporting the conclusion that
Tec1 and Bcr1 functioned downstream of Efg1. These results,
together with those on the mutants of the Ras1/cAMP pathway
and the observations of Nobile and Mitchell [28], define the
following dependent pathway for the regulation of a/a biofilm
formation: Ras1RCdc35RcAMP (Pde2–|)RTpk2(Tpk1)
REfg1RTec1RBcr1.
Expression of Components in the Pathway Regulating a/
a Biofilm Formation
To test whether components of the Ras1/cAMP pathway are
selectively up-regulated during a/a, but not a/a, biofilm
formation, the expression of RAS1, TPK2, EFG1, and BCR1 were
assayed by RT-PCR after 12 and 48 h either under planktonic
conditions (P) or during biofilm development. All four genes were
expressed under planktonic or biofilm conditions, after 12 or 48 h
and in a/a or a/a cells (Figure S2). These results indicate that
Figure 4. Deletion mutants of EFG1 and BCR1 in a/a cells have aberrant phenotypes similar to those of ras1/ras1, cdc35/cdc35, and
tpk2/tpk2. See Table S2 for origins and genotype of strains. (A) Quantitation of adhesion to a plastic surface after 16 h. (B) Images of adhesion of
select strains to the plastic surface of wells after 16 h. (C) Biomass of biofilms formed on an elastomer surface after 48 h. (D) ß-glucan released into
the medium by 48 h biofilms. (E) Thickness of 48 h biofilms. (F) Representative images of cell density at the substratum and 20 mm above the
substratum for 48 h biofilms of select strains. Data in panels A, C, D, and E are presented as mean 6 standard deviation (error bars). Data are from
eight measurements, two per biofilm preparation. (2Dox), in the absence of doxycycline; (+Dox), in the presence of doxycycline. Scale bar in panel F
equals 100 mm.
doi:10.1371/journal.pbio.1001117.g004
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selectively up-regulated during a/a biofilm formation. All are
constitutively expressed.
Overexpression of BCR1 Only Partially Rescues the tec1/
tec1 Mutant Phenotypes in a/a Cells
Nobile et al. [31] demonstrated that overexpression of BCR1 in
the a/a mutant tec1/tec1 partially rescued the defect in biofilm
biomass, but not hypha formation within the biomass, perhaps
because Tec1 is involved in regulating hypha formation indepen-
dently of biofilm formation [59]. If the transcription factor Bcr1
alone regulates biofilm genes and Tec1 regulates only Bcr1
expression in the a/a biofilm pathway, then overexpression of
Bcr1 in a tec1/tec1 background might rescue the adhesion defect,
which is an early developmental stage in the maturation of biofilms
preceding hypha formation and matrix deposition in biofilm
Figure 5. Efg1 functions downstream of the Ras1/cAMP pathway, but upstream of Tec1. To assess the order of function, wild type genes
were placed under the regulation of a tetracycline (doxycycline)-inducable promoter in deletion mutant backgrounds, and tested for biofilm
formation in the absence or presence of doxycycline. See Table S2 for origins and genotypes of mutants. (A) Adhesion when EFG1 was overexpressed
in the deletion mutants efg1/efg1-TETp-EFG1, ras1/ras1-TETp-EFG1, cdc35/cdc35-TETp-EFG1, tpk1/tpk1-TETp-EFG1, and tpk2/tpk2-TETp-EFG1. (B) Gene
expression assessed by RT-PCR when EFG1 was overexpressed. (C) Adhesion when TEC1 or BCR1 was overexpressed in mutants efg1/efg1-TETp-TEC1
and efg1/efg1-TETp-BCR1. (D) Gene expression assessed by RT-PCR when TEC1 or BCR1 was overexpressed in the deletion efg1/efg1 mutant
background. (E) Adhesion when EFG1 was overexpressed in the mutant tec1/tec1-TETp-EFG1 or bcr1/bcr1-TETp-EFG1 mutant. (F) Gene expression
assessed by RT-PCR when EFG1was overexpressed in the tec1/tec1 or bcr1/bcr1 mutant background. Data in panels A, C, and E are presented as mean
6 standard deviation for data from eight measurements, two per biofilm. Dox, doxycycline.
doi:10.1371/journal.pbio.1001117.g005
Two biofilms in Candida albicans
PLoS Biology | www.plosbiology.org 9 August 2011 | Volume 9 | Issue 8 | e1001117development. We, therefore, tested whether overexpression of
BCR1 in the mutant tec1/tec1-TETp-BCR1 restored adhesion.
Overexpression induced by the addition of doxycycline partially
restored adhesion to a level approximately two-thirds that of the
parental strain SC5314 (Figure S3), a result similar to that of
Nobile et al. [31]. These results suggest that although Tec1 is
upstream of Bcr1, both Bcr1 and Tec1 regulate downstream genes
early in a/a biofilm formation.
Efg1 Is Regulated by Phosphorylation
Bockmu ¨hl and Ernst [60] previously demonstrated that the role
of Efg1 in filamentation was regulated through phosphorylation of
a single threonine residue at amino acid 206. Since Efg1 is the first
protein we identified downstream of the cAMP-dependent kinase,
Tpk2 (Tpk1), in the pathway regulating a/a biofilm formation, we
tested whether Efg1 had to be phosphorylated at this site in order
to function in the regulation of a/a biofilm formation. This
represented the only identifiable cAMP-dependent kinase phos-
phorylation site in the deduced amino acid sequence. The deletion
mutant efg1/efg1 was transformed with native EFG1, the derivative
EFG1T206A, which contains alanine instead of threonine at amino
acid 206, thus mimicking the constitutively unphosphorylated
state, and the derivative EFG1T206E, which contains glutamic
acid at amino acid 206, thus mimicking the constitutively
phosphorylated state. The generated strains were efg1/efg1-
TETp-EFG1, efg1/efg1-TETp-EFG1T206A, and efg1/efg1-TETp-
EFG1T206E, all tagged with GFP (Table S2). Western blot
analysis using anti-GFP antibody revealed that in the three
respective strains, the level of Efg1, Efg1T206A, and Efg1T206E
were similarly up-regulated by doxycycline (Figure 6A). Overex-
pression of wild type EFG1 in efg1/efg1-TETp-EFG1 reestablished
wild type levels of adhesion (Figure 6B,C), biofilm biomass
(Figure 6D), released ß-glucan (Figure 6E), and gene expression
(Figure 6F). Overexpression of EFG1T206A,i nefg1/efg1-TETp-
EFG1T206A, resulted in partial increases in adhesion
(Figure 6B,C), biofilm biomass (Figure 6D), released ß-glucan
(Figure 6E), and gene expression (Figure 6F). In each case the
increase was roughly a third of that achieved by overexpression of
wild type EFG1. In marked contrast, overexpression of
EFG1T206E resulted in increases in adhesion (Figure 6B,C),
biofilm biomass (Figure 6D), release of ß-glucan (Figure 6E), and
gene expression (Figure 6F) that were at least as great as that
achieved when wild type EFG1 was overexpressed. Together these
results indicate that Efg1 is activated at least in part in the a/a
biofilm pathway through phosphorylation.
MTL-Homozygous Biofilms Are Not Regulated by Bcr1
The a/a mutant bcr1/bcr1 exhibited adhesion levels after 16 h
of a-pheromone treatment similar to that of wild type a/a cells
(Figure S1A). The subsequent characteristics of the biofilms
formed by the a/a mutant after 48 h (biomass, b-glucan release,
and cell density at the substrate and 20 mm above it) were also
similar to the those of biofilms formed by the a/a wild type strain
in the absence (unenhanced) or presence (enhanced) of minority
opaque a/a cells (Figure S1B, C, and D, respectively). These
results indicate that even though BCR1 is expressed at similar
levels during a/a and a/a biofilm formation, BCR1 is essential
only for the former.
Overexpression of BCR1 Confers Impermeability to a/a
Biofilms
Even though BCR1 transcript levels were similar during a/a
and a/a biofilm formation (Figure S2), BCR1 was essential only
for the former. We, therefore, expected to find that deleting the
gene or overexpressing it would have no effect on the permeability
of a/a biofilms. As expected, deleting BCR1 in the a/a strain
P37005 had no further effect on the high degree of biofilm
permeability (Figure S4A,B). However, overexpressing BCR1 in
strain a/a P37005-TETp-BCR1 (Table S2), by adding doxycy-
cline, resulted in a dramatic decrease in the permeability of
SYPRO Ruby (Figure S4C through E). The decrease was a
function of the level of overexpression. Permeability in parental
P37005 biofilms was 100% (N=9) in 0mg/ml of doxycycline,
34.564.6% (N=9) in 25mg/ml of doxycycline, and 21.964.0%
(N=9) in 50mg per ml of doxycycline (Figure S4C, D, and E,
respectively). Neither deletion of BCR1, in the bcr1/bcr1 a/a
mutant, nor overexpression in strain P37005-TETp-BCR1, affected
biofilm thickness (Figure S4A through E) or in the level of b-glucan
released into the medium (Figure S4F). These results suggest that
in a/a cells, the constitutive level of expression is sufficient to affect
impermeability, but in a/a cells, that constitutive level is
insufficient. Furthermore, Bcr1-induced impermeability does not
appear to involve increased b-glucan synthesis.
Discussion
Permeability, Drug Susceptibility, and Penetrance
The formation of an a/a biofilm and that of a unisexual MTL-
homozygous (a/a or a/a) white cell biofilm follow roughly the
same developmental stages, which include the formation of a basal
layer of yeast phase cells on an adherent surface, the formation
and extension of vertically oriented hyphae from the basal layer,
and the deposition of a polymolecular extracellular matrix. a/a
biofilms are approximately 30% thicker than unisexual a/a or a/
a biofilms, but the thickness of the latter can be enhanced
approximately to that of a/a biofilms by adding a minority of
opaque cells of opposite mating type, a source of pheromone [15].
Here, we tested the hypotheses that although superficially similar,
the function and regulation of the two basic types of biofilms, a/a
and unenhanced a/a or a/a, differ. We have presumed that
because the MTL configuration of a majority of strains (,90%)
causing commensal colonization and infection in nature is a/a [4–
7], a similar majority of biofilms formed in hosts are a/a. Biofilms
formed by a/a cells appear to play the traditional role of
microbial biofilms, providing a controlled, protective multicellular
environment, resistant to environmental challenges [10–14,61–
63]. We therefore expected to find, as we did, that a/a biofilms
formed on silicon elastomers were impermeable to molecules in
the size range of antifungals and antibodies. A number of prior
studies revealed that C. albicans a/a biofilms were resistant to
antifungals [61,64,65] and that resistance late in biofilm
development was not dependent upon the up-regulation of efflux
pumps [65]. The impermeability that we have found to Dead Red,
SYPRO Ruby, and ConA is very likely the basis for the general
resistance to fluconazole and other antifungals [66]. Given this
general impermeability characteristic, it was not surprising to find
that a/a biofilms were also highly resistant to penetration by
human polymorphonuclear leukocytes. Katragkou et al. [67] had
previously performed a similar experiment in which they over-
layed biofilms with monocytes and observed progressive penetra-
tion to the middle layer after 22 h. However, they used a
monocyte/C. albicans cell ratio of 1:1 to 10:1, whereas we used a
ratio of 1:3,000. It is, therefore, difficult to compare their results
with ours. Impenetrability by white blood cells of bacterial biofilms
has also been observed. Bjarnsholt et al. [68] demonstrated that
PMNs did not penetrate biofilms formed by Pseudomonas aeruginosa
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chronic ulcers in the legs and feet of diabetics [69].
Biofilms formed by white a/a or a/a cells have been shown in
vitro to facilitate the mating process between seeded minority
opaque cells of opposite mating type by protecting gradients of
pheromones that direct chemotropism [15,19]. Given that phero-
mones, with a molecular weight of approximately 1.6 kDa, must
readilydiffusethroughan MTL-homozygous biofilm,weconsidered
thepossibilitythat incontrast to a/a biofilms,a/aand a/a biofilms
would be more permeable to low molecular weight molecules.
Moreover, since chemotropism in an MTL-homozygous biofilm
involves extension and penetration of long conjugation tubes with
diameters of up to 1 mm [15], we also considered the possibility that
human PMNs penetrated a/a and a/a biofilms more readily than
they did a/a biofilms. Our results support these predictions. Our
results are consistent with the hypothesis that the main role of a/a
biofilms is to provide an impermeable, impenetrable environment
that protects cells from environmental challenges during commen-
salismand infection,butthat the role ofwhite a/aand a/a biofilms
may be to provide a permeable, penetrable multicellular environ-
ment that functions, at least in part, to support chemotropism and
fusion of opaque cells of opposite mating types in the mating
process. Whatever the role proves to be for MTL-homozygous
biofilms, our results clearly demonstrate for the first time that C.
albicans forms two morphologically similar but functionally distinct
biofilms, depending upon the configuration of the MTL locus.
Figure 6. The activity of Efg1 is regulated by phosphorylation of a threonine, at amino acid 206. The deletion mutant efg1/efg1 was
transformed with EFG1T206A, in which threonine was replaced with alanine, thus mimicking the constitutively unphosphorylated state, or with
EFG1T206E, in which threonine was replaced with glutamic acid, thus mimicking the constitutively phosphorylated state. Both EFG1T206A and
EFG1T206E were placed under the regulation of the tetracycline (doxycycline)-inducible promoter to generate strains efg1/efg1-TETp-EFG1T206A and
efg1/efg1-TETp-EFG1T206E. The transformation constructs were tagged with GFP (see Table S2 for genotypes). Efg1 had previously been shown to be
regulated by phosphorylation at threonine 206 [60]. (A) Levels of expression of Efg1 measured by western blot staining with anti-GFP antibody. (B)
Quantitation of adhesion to a plastic surface after 16 h. (C) Images of adhesion by selective strains to the plastic surface after 16 h. (D) Biomass of
biofilms formed on a silicone elastomer surface after 48 h. (E) ß-glucan released into the medium by 48 h biofilms. (F) Gene expression using RT-PCR
of 48 h biofilms. Data in panels B, D, and E are presented as the means 6 standard deviation. Data are from eight measurements, two per biofilm
preparation.
doi:10.1371/journal.pbio.1001117.g006
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PLoS Biology | www.plosbiology.org 11 August 2011 | Volume 9 | Issue 8 | e1001117Figure 7. Alternative models for the regulation of a/a and a/a or a/a biofilms. (A) a/a cells undergo homozygous to a/a or a/a. (B)
Regulation of a/a biofilm formation. Question marks refer to unknown signal and receptor of this signal transduction pathway. (C) Regulation of a/a
(or a/a) biofilm formation. Regulation of a/a biofilms is assumed to be similar to that of a/a biofilms, for which we have presented evidence. Similar
permeability and penetrability characteristics have been demonstrated for a/a and a/a biofilms. pm, plasma membrane.
doi:10.1371/journal.pbio.1001117.g007
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For C. albicans to form an a/a or a/a white cell biofilm, a/a
cells must first undergo MTL-homozygosis to the a/a or a/a MTL
configuration (Figure 7A), releasing the switching system from a1-
a2 repression [4,8]. White cells of a single mating type (i.e., a/a or
a/a) are then activated through mating type-nonspecific release of
pheromone in a paracrine signaling system [16,17,18] to form an
a/a or a/a biofilm. The a-o ra-pheromone signal is transduced
in white cells by a pathway (Figure 7C) that includes the
pheromone receptors Ste2 or Ste3, respectively, the trimeric G-
protein complex Cag1, Ste4, and Ste18, the MAP kinase cascade
Ste11, Hst7, and Cek1/Cek2, and the MAP kinase scaffold Cst5
(Figure 7C) [20,23,24]. This represents the same upper portion of
the pathway that regulates the opaque cell pheromone response in
the mating process [24]. In the formation of a white a/a biofilm,
the MAP kinase pathway activates the transcription factor Tec1
through phosphorylation [22]. Tec1 then up-regulates biofilm-
related genes by binding to the AT-rich cis-acting sequence WPRE
in the promoters of those genes [18]. Here we have demonstrated
by mutational analysis that although this pathway is essential for
the formation of a white MTL-homozygous biofilm (Figure 7B), it
plays no role in the formation of an a/a biofilm.
Instead, we have found that a/a biofilms are regulated
by the following pathway: Ras1RCdc35RcAMP(Pde2–|)
RTpk2(Tpk1)REfg1RTec1RBcr1 (Figure 7A). Our results
suggest that Tpk2, the cAMP dependent kinase at the end of the
Ras1/cAMP portion of the pathway, is essential for a/a biofilm
formation, and directly or indirectly activates Efg1 through
phosphorylation of threonine 206, the only protein kinase A motif
identifiable in the protein [60,70]. Tpk1, although not essential,
appears to play a facilitating role, apparently by increasing the
efficiency of the response, but is unable to compensate for the
deletion of Tpk2. Except for the role of Bcr1, this represents the
same pathway that regulates hypha formation in a/a cells [42–
48]. It had previously been demonstrated that the transcription
factors Efg1, Tec1, and Bcr1 were necessary for normal a/a
biofilm development, and that Tec1 regulated BCR1 expression
[31]. Since these last three components of the a/a biofilm
pathway are transcription factors, the dependent sequence
Efg1RTec1RBcr1 may be considered a transcription factor
cascade, Efg1 activating Tec1, and Tec1 in turn activating Bcr1.
Given that Bcr1 is at the end of this dependent pathway, one
might conclude that it is ultimately responsible for up-regulating
all a/a biofilm genes. However, overexpression of BCR1 in a tec1/
tec1 background in a/a cells did not fully rescue the mutant
aberrant adhesion phenotype of tec1/tec1, a result similar to that
obtained by Nobile et al. [31], suggesting that Tec1 directly
regulates Bcr1, but both Tec1 and Bcr1 regulate genes that
contribute to a/a biofilm formation, as modeled in Figure 7B.
By mutational analysis, we have also shown that deletion of two
major components of the Ras1/cAMP pathway, RAS1 and TPK2,
has no measurable effect on the formation of a/a biofilms.
Deletion of BCR1 was further shown to have no effect on the high
level of permeability to SYPRO Ruby. We have also shown that
even though RAS1 and TPK2 are expressed constitutively at similar
levels in a/a and a/a cells, they only play a role in the formation
of an a/a biofilm. Therefore, a/a biofilms are regulated by the
Ras1/cAMP pathway, but not the MAP kinase pathway, while
MTL-homozygous (a/a and a/a) biofilms are regulated by the
MAP kinase pathway, but not the Ras1/cAMP pathway (Figure 7).
It should be kept in mind, however, that identification of these
specific pathways does not exclude the existence of additional
alternative or common pathways regulating a/a and MTL-
homozygous biofilms.
Interestingly we have found that even though BCR1 is not
essential for a/a biofilm formation, it is expressed at a level similar
to that in a/a cells. Furthermore, overexpression in a/a cells
results in a decrease in permeability that mimics the imperme-
ability characteristic of a/a biofilms. It is not immediately clear
why overexpression of BCR1 in a/a cells, which already express
BCR1 at a constitutive level, confers this impermeability
characteristic. Together, these results suggest a post-transcriptional
modification process that represses BCR1function, but which
cannot accommodate abnormally higher concentrations of BCR1
when overexpressed. Regardless of the reason for this apparent
paradox, our results suggest that Bcr1 is involved in the regulation
of genes involved in a/a biofilm impermeability.
The Regulation of Hypha Formation in Alternative
Biofilms
The Ras1/cAMP pathway plays a major role in the regulation
of hypha formation in a/a cells [40–43,71,72]. Deletion of
components of this pathway in a/a cells impairs, delays, or blocks
the formation of hyphae. This pathway was then implicated in the
establishment of stationary phase and the starvation response in
a/a cells [43] and CO2, GlcNAc, and glucose induction of the
white to opaque switch in MTL-homozygous cells [44]. Here we
demonstrate that this same pathway plays a key regulatory role in
a/a biofilm formation, which includes early adhesion and
subsequent hypha and matrix formation during biofilm matura-
tion. We also demonstrate that the Ras1/cAMP pathway does not
play a similar role in a/a biofilm formation. In a/a cells, both the
mutants ras1/ras1 and tpk2/tpk2 do not undergo an increase in
adhesion, do not form a uniform yeast basal cell layer early in
biofilm formation, and do not form hyphae vertically oriented in
an extracellular matrix later in biofilm formation. In a/a cells,
however, the same mutants, ras1/ras1 and tpk2/tpk2, form normal
biofilms that include vertically oriented hyphae in a matrix. The
hyphae formed in these mutants are indistinguishable from those
formed by wild type a/a cells and by wild type a/a cells during
biofilm formation. These results indicate that during a/a biofilm
formation, the Ras1/cAMP pathway is involved in the regulation
of early as we well as late events, including hypha and matrix
formation, but in a/a biofilm formation, this pathway is not
involved.
a/a Biofilms May Have Evolved from a/a Biofilms
The major pathogenic species of the Candida clade, including C.
albicans, C. parapsilosis, and C. tropicalis, form biofilms on silicone
elastomers [25]. Although differences have been noted between
these biofilms, including cellular composition, matrix, and drug
susceptibility [10–14,25], the capacity to form a biofilm appears to
be a general characteristic that, like the mating process [24,73–
75], appears to have been conserved throughout the evolution of
this clade. Identifying the signal transduction pathway controlling
a/a biofilm formation in C. albicans should provide a contextual
framework for testing whether biofilm formation in all members of
this clade are similarly regulated.
The results we have obtained here also support the hypothesis
that has been proposed for the evolution of the regulatory pathway
for MTL-homozygous biofilms [22,23]. Because C. albicans [76]
and the closely related species Candida dubliniensis [77] are the only
two members of the Candida clade that have been found to
undergo white-opaque switching and the white cell pheromone
response, these developmental programs most likely evolved in the
ancestor to the two species, approximately 40 million years ago
[19,37]. The upstream portion, from signal and receptor through
the MAP kinase cascade, appears to have been derived completely
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response pathway for mating [20,24]. We must now consider the
possibility that the downstream portion, which includes the
targeted transcription factor Tec1 and the genes it activates,
may have been derived from the downstream portion of the
conserved pathway for a/a biofilm formation [21,23]. The
evolutionary transition, however, could not have been an intact
transfer, as appears to be the case for the upper portion of the
pathway. Two major changes would have had to have taken place.
First, Tec1, which is under the regulation of Efg1 in the a/a
pathway, would have had to come under the regulation of Cek2
(Cek1). Second, Tec1 would have had to lose the capacity to
activate genes through Bcr1, as it does in a/a biofilm formation. If
this hypothesis is correct, then a/a biofilms would benefit from the
genes activated by both Tec1 and Bcr1, whereas a/a and a/a
biofilms would benefit solely from genes activated by Tec1. The
difference, therefore, would be the selective expression of BCR1-
activated genes in a/a biofilms, and could explain the differences
between the two types of biofilms in regard to permeability, drug
susceptibility, and white blood cell penetrance. We have therefore
shown that C. albicans forms two morphologically similar but
functionally distinct biofilms depending upon the configuration of
the MTL locus. The a/a biofilm appears to represent the
conserved form functioning traditionally as an impermeable
impenetrable barrier to host challenges. The a/a or a/a biofilm,
in contrast, appear to represent a recently evolved form, both
permeable and penetrable, which may serve functions related to
the facilitation of mating.
Materials and Methods
Strains and Media
The genotype and origins of all parental, mutant, and
complemented strains employed in this work are listed in Tables
S1 and S2. Strains were standardly grown at 25uC on agar plates
or in liquid either containing modified Lee’s medium [78,79] or
YPD medium [80] prior to experimental use. Deletion mutants
and complemented strains were generated according to methods
previously described [17,18,20], which were adapted from Reuss
et al. [81]. The primers used for the generation of mutants and
complemented strains are presented in Table S3. In select cases, to
obtain a/a or a/a strains from a/a strains, cells were treated with
L-sorbose [82], plated, and opaque sectors (a/a or a/a
derivatives) were selected and analyzed by PCR for the
configuration of the MTL locus.
Gene Overexpression Strategy
A tetracycline-inducible or a methionine-, cysteine-repressible
system was employed for overexpression studies. For tetracycline
(doxycycline) inducibility, the plasmid pNIM1 [49] was used,
which harbors a GFP coding region and the tetracycline-regulated
promoter TETp. The ORF of a gene was amplified by PCR with
the primers listed in Table S3. The amplified fragments were
subcloned into the plasmid pNIM1at the SalI site, to generate
derivatives under the control of TETp. The GFP gene was fused in-
frame to the 3 ` end of the ORF and the correct orientation
confirmed by sequencing. The TETp-gene GFP fusion plasmids
were digested with ApaI plus SacII and transformed into either
wild-type or mutant strains. The constructs were targeted to the
ADH1 locus. Activation of gene transcription by doxycycline was
verified by RT-PCR analysis prior to experimentation. In the case
of CDC35 overexpression, the MET3 repression-based plasmid
pK75.2 [83] was used instead. The CDC35 ORF, derived by PCR
with primers listed in Table S3, was digested with SbfI and ligated
at the PstI site of pK75.2 to derive the overexpression plasmid.
Measurement of Biofilm Formation
Methods for measuring adhesion [15], biofilm biomass [23],
release of b-glucan [18,84], biofilm thickness [20], and cell density
[23] have been described previously in detail. For adhesion assays,
cells were incubated for 16 h on a plastic surface, and for the
remaining assays, cells were incubated for 48 h on a silicone
elastomer surface [15,20].
Constitutively Expressed GFP Strains, Dye Permeability,
and PMN Penetration
To generate strains constitutively expressing GFP, the promoter
of the actin gene (ACT1) was amplified as a 1 kb fragment
upstream of the ATG start codon using primers described in Table
S3. The PCR product was digested with SalI and subcloned into
the SalI-digested, dephosphorylated plasmid pNIM1. The plasmid
was linearized by digestion with ApaI and SacII, and transformed
into isogenic a/a, a/a, and a/a derivatives of strains P37039,
P37037, and SC5314. The fluorescent strains are described in
Table S1.
To determine dye penetration, 48 h biofilms were overlaid with
a solution containing Film Tracer SYPRO Ruby dye (Invitrogen)
for 30 min prior to live confocal imaging, as previously described
[23]. Simultaneous GFP (argon laser 488 excitation/515 emission)
and SYPRO Ruby (argon laser 457 excitation/610 emission)
fluorescent images were acquired as a z-series at 1 mm intervals
through 100 mm. After z-series acquisition, a z-image through the
image stack, perpendicular to the substrate, was generated to
assess the limits of dye penetration.
To assess human polymorphonuclear leukocyte (PMN) pene-
trance, PMNs were purified from venous blood as previously
described [85]. The purified cells were suspended in Hank’s
Balanced Salt Solution (Gibco-BRL, Gaithersburg, MD) at a final
concentration of 1.5610
6 cells/ml, labeled with 1 mM Vybrant
CM-DiI (Molecular Probes, Invitrogen) for 5 min and washed
with RPMI medium. Twenty ml of PMNs were overlaid on 48 h
biofilms and incubated for 3 h at 37uCi n5 %C O 2. Fluorescent
images were acquired as above, but z-slices were acquired.
To assess the effects of fluconazole (Sigma, St. Louis) on cell
viability, 1.5 ml of medium were removed from each well of 48 h
biofilm cultures [15] and replaced with 1.5 ml of fresh RPM1
culture medium. Fluconazole was added to a final concentration of
25 mg per ml. Biofilms were returned to the rocker for an
additional 24 h. Each silicone elastomer disc with attached biofilm
was briefly rinsed with PBS and placed in a 1.5 ml Eppendorf tube
containing 1 ml of Dulbecco’s PBS without cations, supplemented
with 20 mM EDTA. The biofilms were incubated for 5 min and
vigorously vortexed to remove the biofilm from the elastomer
disks. The cleared elastomer disk was removed and the efficiency
of biofilm assessed microscopically. The biofilm cells were pelleted
and resuspended in PBS containing 0.25 mM Dead Red, a dead
cell nuclear stain (Invitrogen). The total number of cells in a
microscopic field (206objective) was counted and the number of
labeled nuclei in the same field determined by excitation at
543 nm. Three fields were counted for duplicate biofilms of each
strain.
RT-PCR
Treatment with a 0.05% trypsin-EDTA solution (Invitrogen)
released biofilms from the substrate. Total RNA was extracted
using the RNeasy Mini Kit (Qiagen, Valencia, CA). Reverse
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analyze gene expression levels according to methods previously
described [16,23,31,86]. The primers used are listed in Table S4.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed for EFG1 according to
methods previously described [23]. In brief, the 59 and 39 portions
of the EFG1 gene flanking the site to be mutated were amplified by
PCR using primers listed in Table S3. The two DNA fragments
were then fused together by PCR using 59 and 39 primers. The
resulting mutated ORF was digested with SalI and subcloned into
the SalI-digested, dephosphorylated plasmid pNIM1. GFP was
fused in-frame to the C-terminal region of the mutated versions of
EFG1 and its mutant derivatives. The plasmid was then digested
with ApaI and SacII and transformed into the homozygous
deletion mutant efg1/efg1. The derived point mutants were verified
by PCR and sequencing.
Western Blotting
Western blots were performed according to methods previously
described [23,44].
Supporting Information
Figure S1 Ras1, Tpk2, and Bcr1 play no measurable role in a/a
biofilm formation. Parental and mutant a/a strains are generated
from a/a strains (see Table S2 for genotype origins and
references). Methods can be found in Materials and Methods.
Scale bar equals 100 mm. Note that in panels E and G, the use of a
projection image obscures the true patchiness of the cell layers on
the substratum.
(TIF)
Figure S2 Expression of RAS1, TPK2, EFG1, and BCR1 in
biofilms formed by a/a strain P37005 and a/a strain SC5314
under planktonic growth (P) and biofilm formation (BF) after 12
and 48 h of development. Methods can be found in Materials and
Methods. TDH expression is known to be constitutive.
(TIF)
Figure S3 Overexpression of BCR1 in a tec1/tec1 mutant in a/a
cells only partially rescues the defective adhesion phenotype.
(TIF)
Figure S4 Overexpression of BCR1 in the a/a strain P37005
results in an increase in impermeability to Sypro Ruby. Thickness
(Thick.) and permeability (Perm.) were quantitated. (A through E)
Sypro Ruby staining of 48-h, live biofilms. (F) b-glucan released
into medium. Scale bar equals 100 mm.
(TIF)
Table S1 GFP-tagged strains used for biofilm dye permeability,
cell penetration, and fluconazole susceptibility.
(DOC)
Table S2 Strains used in mutant studies.
(DOCX)
Table S3 Oligonucleotides used for mutant construction.
(DOC)
Table S4 Primer used for RT-PCR.
(DOCX)
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